Clinical trial
Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid…
NCT00084734 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00084734 |
|---|---|
| Title | Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors |
| Official title | A Phase I and Pharmacokinetics Study of Docetaxel in Combination With Capecitabine and Cisplatin in Solid Tumors |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | capecitabine, cisplatin, docetaxel |
| Enrollment | 61 |
| Start date | May 1, 2002 |
| Primary completion | Nov 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Jun 11, 2004 |
| Last update posted | Aug 4, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: